This content is machine translated Type 2 diabetes “Swiss Diabetes Guide” – digital tool supports physicians in drug selection The treatment options for type 2 diabetes mellitus are very complex. In addition to the large number of new active ingredients on the market, the scientific data base is constantly…
View Post 2 min This content is machine translated Diabetes Therapy Tirzepatide convinces with superior HbA1c and weight reduction The dual GLP-1/GIP receptor agonist tirzepatide is currently being evaluated in Phase III clinical trials. In adult type 2 diabetics at increased cardiovascular risk, tirzepatide resulted in superior HbA1c and…
View Post 3 min This content is machine translated Chronic wounds Cold plasma promotes wound healing in diabetic foot ulcers A study showed that treatment of diabetic foot ulcers with cold atmospheric plasma improves oxygen and nutrient supply to damaged tissue layers, stimulates blood flow and activates wound healing. This…
View Post 7 min This content is machine translated Non-alcoholic fatty liver disease NAFLD and diabetes – a dangerous duo The prevalence of non-alcoholic liver disease (NAFLD) and type 2 diabetes is increasing worldwide. Obesity, dyslipidemia, and insulin resistance are major risk factors for NAFLD and steatohepatitis (NASH). Targeted screening…
View Post 16 min This content is machine translated Type 2 diabetes The cardiovascular diabetic patient – an interdisciplinary challenge A patient with type 2 diabetes is 2-3 times more likely to have a myocardial infarction or stroke than people without diabetes. Cardiovascular disease accounts for up to 50% of… CME-Test
View Post 9 min This content is machine translated The ASCLEPIOS studies Ofatumumab has the potential to be a game changer Prof. Ludwig Kappos, M.D., Basel, Switzerland, together with Prof. Stephen L. Hauser, M.D., Director of the UCSF Weill Institute for Neurosciences, San Francisco, USA, chaired the Steering Committee of the…
View Post 3 min This content is machine translated Primary immunodeficiencies Observe warning signs and react! Although most primary immunodeficiencies (PGDs) manifest in childhood, the disease is often not recognized until adulthood [1]. In this context, only early diagnosis can reduce morbidity and prevent deaths [2].
View Post 1 min This content is machine translated Type 2 diabetes mellitus X-CHANGE 2021 In the management of type 2 diabetes mellitus, there is currently a paradigm shift from blood glucose management to a whole organ protection approach. The main aim is to protect… CME-Test
View Post 2 min This content is machine translated Diabetes Management Fresh wind through new possibilities – what is now possible In addition to the metabolic syndrome, type 2 diabetes also affects the blood vessels, heart and kidneys, among other things – this has been revealed by scientific research into the…
View Post 13 min This content is machine translated Gerontopsychiatry Focus on polypharmacy – challenges and solutions With age, diseases increase – and so does the likelihood of polypharmacy. However, this presents many challenges, as the heterogeneity and vulnerability of older people requires a differentiated approach. Patients… CME-Test
View Post 6 min This content is machine translated Early detection of primary immunodeficiency Background, warning signs and diagnosis Defects of the immune system can have devastating consequences [1]. However, because the symptoms are very diverse, the diagnosis of primary immunodeficiency often occurs late [2]. However, early detection is…
